oral semaglutide launch Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic injection for Type 2 diabetes, at just ₹4,200/month ACC 2025: Oral Semaglutide Reduces

Methods Study Design and Patients This study was a retrospective chart review with longitudinal data carried out in a single Canadian endocrinology clinic with five endocrinologists on consecutive eligible patients

At scale, this shift signals a structural reset in the food and beverage profit pool, with volume driven brands under pressure and value dense offerings pulling ahead

The only side effect is my loss of appetite, which is a good thing, he said

[2] [3] NICE guidance for obesity management acknowledges this uncertainty whilst supporting the use of these agents when clinically appropriate, emphasising the importance of patient selection and monitoring

Many people worry that one missed injection means treatment has failed

Rheumatoid Arthritis Is More Than Just Your Joints Rheumatoid Arthritis Is a Whole-Body Disease Many people hear the term "rheumatoid arthritis" and assume it is simply a condition that affects the joints